Moreover, EGFR inhibitors may limit HNSCC malignancy not only through the inhibition of EGFR signaling but also by impairing exosome‐mediated communication via macropinocytosis 29. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.